Skip to main content

Table 2 Univariate and multivariate analysis of disease free survival in CRC patients with stage II-III

From: Methylated septin 9 gene is an important prognostic marker in stage II and stage III colorectal cancer for evaluating local recurrence or distant metastasis after surgery

Parameter

Univariate analysis, HR (95% CI)

P

Mutivariate analysis, HR (95% CI)

P

Gender

 Male

1 (Referent)

0.384

 Femal

0.728 (0.357–1.488)

Age

60 yr

1 (Referent)

0.929

 >60 yr

0.970 (0.499–1.887)

T stage

 T2-3

1 (Referent)

0.007

 T4

3.346 (1.388–8.065)

N stage

 N0

1 (Referent)

 < 0.001

 N1

1.312 (0.508–3.384)

 N2

5.290 (2.464–11.355)

TNM stage

 II

1 (Referent)

0.005

1 (Referent)

0.003

 III

2.789 (1.365–5.700)

3.010 (1.470–6.163)

 

Vascular invasion

 Absent

1 (Referent)

0.085

 Present

2.006 (1.015–3.964)

Location

 Right Colon

1 (Referent)

0.090

 Left Colon

0.345 (0.128–0.933)

   

 Rectum

0.858 (0.405–1.817)

Microsatellite

 pMMR

1 (Referent)

0.118

 dMMR

2.129 (0.825–5.494)

mSEPT9

 Negative

1 (Referent)

0.020

1 (Referent)

0.009

 Positive

2.509 (1.175–5.359)

2.741 (1.281–5.865)

  1. pMMR: proficient mismatch repair; dMMR: different mismatch repair;
  2. mSEPT9: methylated septin 9 gene; CRC: colorectal cancer